About: Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

AttributesValues
rdf:type
description
  • clinical trial (en)
  • ensayu clínicu (ast)
  • klinisch onderzoek (nl)
  • клінічне випробування (uk)
rdfs:label
  • Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer (en)
  • Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer (nl)
skos:prefLabel
  • Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer (en)
  • Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer (nl)
name
  • Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer (en)
  • Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer (nl)
title
title
  • Randomized, Double-blind, Phase 3 Study Evaluating TAS-102 Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Patients With Metastatic Gastric Cancer Refractory to Standard Treatments (en)
end time
end time
instance of
instance of
start time
start time
country
country
research site
research site
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software